Stock listing
NASDAQ:BMTI Biomimetic Therapeutics Inc Stock
Follow Biomimetic Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:BMTI
$9.49 USD
Close on Feb 28, 2013 · No longer trades
- Lowest – highest close
- $1.91 – $18.98 USDSince May 15, 2006 · lowest Jan 9, 2012 · highest Jun 4, 2007
Delisted NASDAQ:BMTI no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:BMTI
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Biomimetic Therapeutics Inc on 6ix
- Decks
- 13 decks · latest Jan 8, 2013
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| 31st Annual J.P. Morgan Healthcare Conference 2013 | Conference | 41 slides | Jan 8, 2013 |
| Technical Presentation (June 2012) | Technical | 26 slides | Jun 21, 2012 |
| Jefferies Global Healthcare Conference 2011 | Conference | 36 slides | Jun 10, 2011 |
| Investor Day (February 2011) | Investor day | 113 slides | Feb 23, 2011 |
| 2010 AOFAS Annual Summer Meeting | Conference | 19 slides | Jul 7, 2010 |
| Technical Presentation (July 2010) | Technical | 19 slides | Jul 7, 2010 |
| Technical Presentation (March 2010) | Technical | 25 slides | Mar 12, 2010 |
| Investor Presentation (March 2010) | Investor deck | 19 slides | Mar 12, 2010 |
| Technical Presentation (March 2010) | Technical | 16 slides | Mar 10, 2010 |
| Investor Day (March 2008) | Investor day | 37 slides | Mar 10, 2008 |
All 13 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (March 2008) | Technical | 12 slides | Mar 10, 2008 |
| Technical Presentation (July 2007) | Technical | 24 slides | Jul 16, 2007 |
| Technical Presentation (November 2006) | Technical | 14 slides | Nov 6, 2006 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Christopher B Ehrlich Other companies: CERo Therapeutics Holdings, Inc. (Chairman and CEO, Director · Since at least Oct 5, 2021); Launch One Acquisition Corp. (Chief Executive Officer, Director · Jul 11, 2024 – Jul 11, 2024 · Past); eFFECTOR Therapeutics Inc (Director · Aug 25, 2021 – Jun 13, 2024 · Past); Paratek Pharmaceuticals Inc (Director · Jan 30, 2009 – Apr 10, 2013 · Past) | Director · May 10, 2006 – Mar 1, 2013 · Past |
| Douglas G Watson Other companies: Delcath Systems, Inc. (Director · Jul 12, 2010 – Jul 10, 2014 · Past); Dendreon Corp (Director · Jun 8, 2006 – Jan 3, 2014 · Past); Engelhard Corp (Director · Mar 15, 2006 – Jun 9, 2006 · Past); OraSure Technologies, Inc. (Director · Jan 23, 2006 – Nov 13, 2016 · Past) | Director · May 9, 2006 – Mar 1, 2013 · Past |
| Earl Douglas Other companies: Allogene Therapeutics, Inc. (General Counsel · Since at least Aug 14, 2023) | General Counsel · May 10, 2006 – Mar 26, 2012 · Past |
| James G Murphy Other companies: Immunicon Corp (Sr. VP and CFO · Jan 17, 2006 – Jan 24, 2008 · Past) | Director · May 10, 2006 – Mar 1, 2013 · Past |
| Samuel Eugene Lynch Other companies: Capital Bank Financial Corp (Director · Oct 1, 2012 – Oct 1, 2012 · Past) | President and CEO, Director · May 10, 2006 – Mar 1, 2013 · Past |
| Gary E Friedlaender | Director · Sep 22, 2006 – Mar 1, 2013 · Past |
| Russell P Pagano | VP, Reg. & Clinical Affairs · May 23, 2007 – Mar 1, 2013 · Past |
| Thorkil K Christensen | Director · Jun 18, 2009 – Mar 1, 2013 · Past |
Log in to ask 6ix AI your own questions about Biomimetic Therapeutics Inc.